Frequency and timing of clinical venous thromboembolism after major joint surgery.

PubWeight™: 1.56‹?› | Rank: Top 4%

🔗 View Article (PMID 16498018)

Published in J Bone Joint Surg Br on March 01, 2006

Authors

B T Bjørnarå1, T E Gudmundsen, O E Dahl

Author Affiliations

1: Department of Radiology, Buskerud Hospital and University College, Dronninggt. 28, 3004 Drammen, Norway.

Articles citing this

Prevention of VTE in orthopedic surgery patients: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest (2012) 5.99

Duration and magnitude of the postoperative risk of venous thromboembolism in middle aged women: prospective cohort study. BMJ (2009) 4.99

Dabigatran, rivaroxaban, or apixaban versus enoxaparin for thromboprophylaxis after total hip or knee replacement: systematic review, meta-analysis, and indirect treatment comparisons. BMJ (2012) 2.99

Symptomatic pulmonary embolus after joint arthroplasty: stratification of risk factors. Clin Orthop Relat Res (2013) 1.25

CT pulmonary angiography after total joint arthroplasty: overdiagnosis and iatrogenic harm? Clin Orthop Relat Res (2013) 1.23

Thromboprophylaxis in spinal surgery: a survey. J Orthop Surg Res (2012) 0.99

Pharmacogenetic-guided dosing of coumarin anticoagulants: algorithms for warfarin, acenocoumarol and phenprocoumon. Br J Clin Pharmacol (2014) 0.97

Symptomatic venous thromboembolism and mortality in orthopaedic surgery - an observational study of 45 968 consecutive procedures. BMC Musculoskelet Disord (2013) 0.95

Preoperative versus postoperative initiation of thromboprophylaxis following major orthopedic surgery: safety and efficacy of postoperative administration supported by recent trials of new oral anticoagulants. Thromb J (2011) 0.95

Total joint arthroplasty and the risk of myocardial infarction: a general population, propensity score-matched cohort study. Arthritis Rheumatol (2015) 0.92

Nonadherence in outpatient thrombosis prophylaxis with low molecular weight heparins after major orthopaedic surgery. Clin Orthop Relat Res (2010) 0.89

The efficacy and safety of rivaroxaban for venous thromboembolism prophylaxis after total hip and total knee arthroplasty. Thrombosis (2013) 0.87

Aspirin: an alternative for pulmonary embolism prophylaxis after arthroplasty? Clin Orthop Relat Res (2014) 0.83

Rationale and design of XAMOS: noninterventional study of rivaroxaban for prophylaxis of venous thromboembolism after major hip and knee surgery. Vasc Health Risk Manag (2012) 0.83

Screening for deep vein thrombosis after periacetabular osteotomy in adult patients: is it necessary? Clin Orthop Relat Res (2014) 0.80

Management of Venous Thromboembolisms: Part I. The Consensus for Deep Vein Thrombosis. Zhonghua Minguo Xin Zang Xue Hui Za Zhi (2016) 0.80

Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol (2010) 0.79

Venous thromboembolic prophylaxis for hip fractures. Osteoporos Int (2010) 0.78

New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders. Vasc Health Risk Manag (2012) 0.76

Biomarkers of Coagulation and Fibrinolysis during Cemented Total Hip Arthroplasty with Pre- versus Postoperative Start of Thromboprophylaxis. Thrombosis (2013) 0.75

Safety and efficacy of switching from low molecular weight heparin to dabigatran in patients undergoing elective total hip or knee replacement surgery. Thromb J (2015) 0.75

The compliance of thromboprophylaxis affects the risk of venous thromboembolism in patients undergoing hip fracture surgery. Springerplus (2016) 0.75

Thromboembolic disease in patients with rheumatoid arthritis undergoing joint arthroplasty: Update on prophylaxes. World J Orthop (2014) 0.75

Prophylaxis for Venous Thromboembolism Following Total Knee Arthroplasty: A Survey of Korean Knee Surgeons. Knee Surg Relat Res (2016) 0.75

Impact of recent guideline changes on aspirin prescribing after knee arthroplasty. J Orthop Surg Res (2016) 0.75

Meta-analysis and suggested guidelines for prevention of venous thromboembolism (VTE) in foot and ankle surgery. Knee Surg Sports Traumatol Arthrosc (2016) 0.75

Metabolic syndrome increases risk for pulmonary embolism after hip and knee arthroplasty. Croat Med J (2013) 0.75

Analysis of disease patterns and cost of treatments for prevention of deep venous thrombosis after total knee or hip replacement: results from the Practice Analysis of THromboprophylaxis after Orthopaedic Surgery (PATHOS) study. Clinicoecon Outcomes Res (2012) 0.75

[Prevention of venous thromboembolism in musculoskeletal surgery]. Wien Klin Wochenschr (2014) 0.75

Similar Clinical Outcomes with Preoperative and Postoperative Start of Thromboprophylaxis in THA: A Register-based Study. Clin Orthop Relat Res (2017) 0.75

Articles by these authors

Oral dabigatran etexilate vs. subcutaneous enoxaparin for the prevention of venous thromboembolism after total knee replacement: the RE-MODEL randomized trial. J Thromb Haemost (2007) 3.66

Extended out-of-hospital low-molecular-weight heparin prophylaxis against deep venous thrombosis in patients after elective hip arthroplasty: a systematic review. Ann Intern Med (2001) 2.37

Dabigatran versus enoxaparin for prevention of venous thromboembolism after hip or knee arthroplasty: a pooled analysis of three trials. Thromb Res (2010) 1.93

A new oral direct thrombin inhibitor, dabigatran etexilate, compared with enoxaparin for prevention of thromboembolic events following total hip or knee replacement: the BISTRO II randomized trial. J Thromb Haemost (2005) 1.70

[Clinical diagnosis of deep venous thrombosis after hip replacement surgery]. Tidsskr Nor Laegeforen (1997) 1.67

The direct thrombin inhibitor melagatran followed by oral ximelagatran compared with enoxaparin for the prevention of venous thromboembolism after total hip or knee replacement: the EXPRESS study. J Thromb Haemost (2003) 1.57

Oral, direct Factor Xa inhibition with BAY 59-7939 for the prevention of venous thromboembolism after total hip replacement. J Thromb Haemost (2006) 1.44

Late occurring clinical deep vein thrombosis in joint-operated patients. Acta Orthop Scand (2000) 1.42

Dose escalating safety study of a new oral direct thrombin inhibitor, dabigatran etexilate, in patients undergoing total hip replacement: BISTRO I. J Thromb Haemost (2004) 1.17

Safety assessment of new antithrombotic agents: lessons from the EXTEND study on ximelagatran. Thromb Res (2008) 1.05

Association between asymptomatic deep vein thrombosis detected by venography and symptomatic venous thromboembolism in patients undergoing elective hip or knee surgery. J Thromb Haemost (2007) 1.00

Timing of initial administration of low-molecular-weight heparin prophylaxis against deep vein thrombosis in patients following elective hip arthroplasty: a systematic review. Arch Intern Med (2001) 1.00

Orthopaedic thromboprophylaxis: limitations of current guidelines. J Bone Joint Surg Br (2008) 0.96

The incidence of gastric ulcer and duodenal ulcer in north Norway. A prospective epidemiological study. Scand J Gastroenterol (1985) 0.96

Thromboembolism--an academic concern or a clinical reality? Acta Orthop Scand (1999) 0.92

No difference in mortality between cemented and uncemented hemiprosthesis for elderly patients with cervical hip fracture. A prospective randomized study on 334 patients over 75 years. Arch Orthop Trauma Surg (2013) 0.91

Smoking, alcohol, coffee, and familial factors: any associations with peptic ulcer disease? A clinically and radiologically prospective study. Scand J Gastroenterol (1985) 0.91

Sustained prothrombotic profile after hip replacement surgery: the influence of prolonged prophylaxis with dalteparin. J Thromb Haemost (2003) 0.91

Midline anterior and posterior atlas clefts may simulate a Jefferson fracture. A report of 2 cases. Acta Orthop Scand (1995) 0.87

Single-drug chemotherapy with 5-FU and adriamycin in metastatic bladder cancer. Br J Urol (1981) 0.86

AVE5026, a new hemisynthetic ultra-low-molecular-weight heparin for the prevention of venous thromboembolism in patients after total knee replacement surgery--TREK: a dose-ranging study. J Thromb Haemost (2009) 0.85

Partial factor IXa inhibition with TTP889 for prevention of venous thromboembolism: an exploratory study. J Thromb Haemost (2007) 0.85

Update of the recommendations on biosimilar low-molecular-weight heparins from the Scientific Subcommittee on Control of Anticoagulation of the International Society on Thrombosis and Haemostasis. J Thromb Haemost (2013) 0.83

Three dimensional CT evaluation of occipito-atlanto-axial dislocation in rheumatoid arthritis. Scand J Rheumatol (1998) 0.78

[Osteomyelitis as a complication of varicella]. Tidsskr Nor Laegeforen (1998) 0.78

[Thrombosis prevention after hip arthroplasty]. Tidsskr Nor Laegeforen (1998) 0.75

Low-molecular-weight heparin prophylaxis against thromboembolism after total hip replacement--the never-ending story? Acta Orthop Scand (2001) 0.75

Renal angiography may be used primarily in the diagnosis of renovascular hypertension. Scand J Urol Nephrol (1988) 0.75

[Anomalies of the inferior vena cava]. Tidsskr Nor Laegeforen (1987) 0.75

[Ventricular ulcer and duodenal ulcer. An epidemiological study based on a radiological study in Troms]. Tidsskr Nor Laegeforen (1986) 0.75

[Urography. Presentation of 3,856 patients in Tromsö examined for the first time]. Tidsskr Nor Laegeforen (1987) 0.75

[Krukenberg tumor. A seldom considered condition?]. Tidsskr Nor Laegeforen (1997) 0.75

[Spigelian hernia misdiagnosed as inguinal hernia]. Tidsskr Nor Laegeforen (1988) 0.75

[Retrograde ileography. Contrast imaging of the terminal ileum by colonoscopy]. Tidsskr Nor Laegeforen (1990) 0.75

[Paraosteoarthropathy. A frequently overlooked phenomenon?]. Tidsskr Nor Laegeforen (1974) 0.75

[Automatic suture stapling in abdominal hysterectomy]. Tidsskr Nor Laegeforen (1986) 0.75

[Hysterosalpingography with a vaccum uterine cannula]. Tidsskr Nor Laegeforen (1974) 0.75

[Abnormality as differential diagnosis in atlas fracture]. Tidsskr Nor Laegeforen (1997) 0.75

[Synovial chondromatosis]. Tidsskr Nor Laegeforen (1992) 0.75

[Amebic liver abscess]. Tidsskr Nor Laegeforen (1990) 0.75

Arteriography of Castleman tumour of the mesentery. Br J Radiol (1981) 0.75

[The os supratrochleare]. Tidsskr Nor Laegeforen (1987) 0.75

[Urinary tract infections in women. Should intravenous urography be done in recurrent infections?]. Tidsskr Nor Laegeforen (1988) 0.75

Intravenous urography in children and youth. Pediatr Radiol (1987) 0.75

[Regional drug purchasing. Of what significance are equivalent drugs]. Tidsskr Nor Laegeforen (1996) 0.75

[Salivary gland ultrasonography]. Tidsskr Nor Laegeforen (1991) 0.75

Seasonal periodicity of peptic ulcer disease. A prospective radiologic study. Scand J Gastroenterol (1985) 0.75

Acute osteomyelitis as a complication of varicella. Acta Radiol (2005) 0.75

[Ultrasonography in ophthalmology]. Tidsskr Nor Laegeforen (1988) 0.75

Changes in diagnostic imaging routines of the stomach and the large bowel during the period between 1975 and 1992. Clin Imaging (1995) 0.75

[Idiopathic omental infarction]. Tidsskr Nor Laegeforen (1988) 0.75

[Primary peritonitis in children]. Tidsskr Nor Laegeforen (1991) 0.75

[Ultrasonography in deep venous thrombosis]. Tidsskr Nor Laegeforen (1989) 0.75

Autosomal dominant osteopetrosis: report of a Norwegian family with radiographic or anamnestic findings differing from the generally accepted classification. Skeletal Radiol (1997) 0.75

[Automatic suture stapling in low rectal anastomosis. EEA and TA-55]. Tidsskr Nor Laegeforen (1986) 0.75

[Urography in hypertension. Practical consequences of recent information]. Tidsskr Nor Laegeforen (1986) 0.75

[Soft tissue ossifications as a complication of paralysis caused by subarachnoid hemorrhages]. Tidsskr Nor Laegeforen (1976) 0.75

Congenital absence of the entire inferior vena cava. The diagnostic significance of varicose veins of the abdominal wall. Acta Chir Scand (1987) 0.75

Intravenous urography and voiding cystoureterography in northern Norway: a retrospective study. Pediatr Radiol (1986) 0.75

Thromboembolism and thromboprophylaxis in high risk surgery: facts and assumptions--a topic for emotions? Eur J Anaesthesiol (2000) 0.75

[Ultrasonography of palpable masses in the breast]. Tidsskr Nor Laegeforen (1985) 0.75

[The bone cement implantation syndrome]. Tidsskr Nor Laegeforen (1984) 0.75

[Skeletal changes in neurofibromatosis]. Tidsskr Nor Laegeforen (1978) 0.75

[Dystopia coeci proximolateralis. A possible cause of diffuse abdominal complaints]. Tidsskr Nor Laegeforen (1985) 0.75

[Acute pulmonary failure syndrome in adults]. Tidsskr Nor Laegeforen (1991) 0.75

[Osteochondritis dissecans tali]. Tidsskr Nor Laegeforen (1976) 0.75

Radiographic measurements of occipito-atlanto-axial dislocation in rheumatoid arthritis. Scand J Rheumatol (1990) 0.75

Accessory ossicles in the elbow. Acta Orthop Scand (1987) 0.75

[Arteriovenous fistula as a complication of percutaneous renal biopsy]. Tidsskr Nor Laegeforen (1995) 0.75

[Osteochondritis dissecans cubiti]. Tidsskr Nor Laegeforen (1976) 0.75

[Has urography some place in the examination of hypertension?]. Tidsskr Nor Laegeforen (1983) 0.75

[Urography in children. Indications and findings]. Tidsskr Nor Laegeforen (1987) 0.75

[Pulmonary echinococcosis. Has the disease been eradicated in North Norway?]. Tidsskr Nor Laegeforen (1987) 0.75